IPO
In Conversation: Matthew McKnight, Chief Commercial Officer, Ginkgo Bioworks
Synthetic.com’s publisher and editor, Simons Chase, interviews Matthew McKnight. Matt is the Chief Commercial Officer of Ginkgo Bioworks where h...
DISCOVERIES
How Immune Macrophages Communicate
Students of synthetic biology soon discover that living things are more adaptive and creative than most people ever imagined. According to Perry Marsh...
STARTUPS
Tome Biosciences Defies Biotech Gloom
Earlier this year, a Jefferies analyst quantified the market downturn in the biotechnology sector and came up with a number: 128 companies were tradin...
SCIENCE
Immunotherapy: The Making Of A Revolution
To learn how something works is to understand how it’s built. How it came to be. That’s true not only if you play a guitar or repair motorcycle engine...
